Researchers tackle elusive Valley Fever vaccine
Is Valley Fever the next epidemic? In Arizona, where the fungal disease thrives, it’s a major health concern—one that’s increasing as climate change leads to hotter, drier regions nationwide. It’s critical enough that congressional leaders gave the National Institutes of Health a mandate to develop a Valley Fever vaccine in the next decade. Paul Keim, executive director of the Pathogen and Microbiome Institute, is leading a $7.5 million collaborative effort with the University of Washington School of Medicine to develop that vaccine, with PMI professors Bridget Barker and Erik Settles playing key roles in the research.
|